| scholarly article | Q13442814 |
| P50 | author | John Dick | Q6229356 |
| Magnus Gottfredsson | Q37371860 | ||
| Gideon M. Hirschfield | Q37829929 | ||
| Yenan Bryceson | Q40448764 | ||
| Mikko Seppänen | Q42276109 | ||
| Naomi Mcgovern | Q42762867 | ||
| Stephen Jolles | Q43122863 | ||
| Eleonora Gambineri | Q43300293 | ||
| Venetia Bigley | Q55473581 | ||
| Chris M Bacon | Q56434360 | ||
| Sasan Zandi | Q58329566 | ||
| James E Thaventhiran | Q60706508 | ||
| Alexander Langridge | Q63969345 | ||
| Muzlifah Haniffa | Q65560182 | ||
| Sophie Hambleton | Q87744473 | ||
| Josef T Prchal | Q88569926 | ||
| Andrew R Gennery | Q89004572 | ||
| Laura Jardine | Q91652149 | ||
| Sarah Pagan | Q125260797 | ||
| P2093 | author name string | Rachel E Dickinson | |
| Matthew Helbert | |||
| Sabina I Swierczek | |||
| Eleni Tholouli | |||
| Tarja Heiskanen-Kosma | |||
| Matthew Collin | |||
| Emma Morris | |||
| Alex G Richter | |||
| Carl Allen | |||
| Paul Milne | |||
| Sari Hämäläinen | |||
| Sharon Cookson | |||
| Sigrún Reykdal | |||
| Zaveyna Ferozepurwalla | |||
| P2860 | cites work | Ligand for FLT3/FLK2 receptor tyrosine kinase regulates growth of haematopoietic stem cells and is encoded by variant RNAs | Q24310069 |
| Autosomal dominant and sporadic monocytopenia with susceptibility to mycobacteria, fungi, papillomaviruses, and myelodysplasia | Q24634431 | ||
| Two subsets of memory T lymphocytes with distinct homing potentials and effector functions | Q28146072 | ||
| Biochemical and genetic characterization of multiple splice variants of the Flt3 ligand | Q28587182 | ||
| Haploinsufficiency of GATA-2 perturbs adult hematopoietic stem-cell homeostasis | Q28587266 | ||
| GATA2 haploinsufficiency caused by mutations in a conserved intronic element leads to MonoMAC syndrome | Q28704337 | ||
| Exome sequencing identifies GATA-2 mutation as the cause of dendritic cell, monocyte, B and NK lymphoid deficiency. | Q30368393 | ||
| Cytometry by time-of-flight shows combinatorial cytokine expression and virus-specific cell niches within a continuum of CD8+ T cell phenotypes | Q30543634 | ||
| Mice lacking flt3 ligand have deficient hematopoiesis affecting hematopoietic progenitor cells, dendritic cells, and natural killer cells | Q30873503 | ||
| NK cell terminal differentiation: correlated stepwise decrease of NKG2A and acquisition of KIRs | Q33654187 | ||
| Levels of soluble CD40 ligand (CD154) in serum are increased in human immunodeficiency virus type 1-infected patients and correlate with CD4(+) T-cell counts | Q33943382 | ||
| Antimicrobial activity of mucosal-associated invariant T cells | Q34022899 | ||
| Mutations in GATA2 are associated with the autosomal dominant and sporadic monocytopenia and mycobacterial infection (MonoMAC) syndrome. | Q34192317 | ||
| Myelodysplasia in autosomal dominant and sporadic monocytopenia immunodeficiency syndrome: diagnostic features and clinical implications | Q35143513 | ||
| Heritable GATA2 mutations associated with familial myelodysplastic syndrome and acute myeloid leukemia | Q35249294 | ||
| Successful allogeneic hematopoietic stem cell transplantation for GATA2 deficiency. | Q35266306 | ||
| Loss-of-function germline GATA2 mutations in patients with MDS/AML or MonoMAC syndrome and primary lymphedema reveal a key role for GATA2 in the lymphatic vasculature | Q35750366 | ||
| Germ-line GATA2 p.THR354MET mutation in familial myelodysplastic syndrome with acquired monosomy 7 and ASXL1 mutation demonstrating rapid onset and poor survival. | Q36006394 | ||
| Conditional Gata2 inactivation results in HSC loss and lymphatic mispatterning | Q36290250 | ||
| Cis-element mutated in GATA2-dependent immunodeficiency governs hematopoiesis and vascular integrity | Q36290255 | ||
| CD8 T cells express randomly selected KIRs with distinct specificities compared with NK cells | Q36352518 | ||
| GATA-2 plays two functionally distinct roles during the ontogeny of hematopoietic stem cells | Q36403822 | ||
| Preventing preterm births: analysis of trends and potential reductions with interventions in 39 countries with very high human development index | Q36611197 | ||
| Mutations in GATA2 cause human NK cell deficiency with specific loss of the CD56(bright) subset. | Q36743341 | ||
| The inverted CD4/CD8 ratio and associated parameters in 66-year-old individuals: the Swedish HEXA immune study | Q36795190 | ||
| Hematopoiesis is not clonal in healthy elderly women. | Q36941071 | ||
| High frequency of GATA2 mutations in patients with mild chronic neutropenia evolving to MonoMac syndrome, myelodysplasia, and acute myeloid leukemia. | Q37023060 | ||
| Feedback control of regulatory T cell homeostasis by dendritic cells in vivo | Q37331528 | ||
| Clinical and biological implications of driver mutations in myelodysplastic syndromes | Q37334716 | ||
| Acquired ASXL1 mutations are common in patients with inherited GATA2 mutations and correlate with myeloid transformation | Q37552020 | ||
| NK cell responses to cytomegalovirus infection lead to stable imprints in the human KIR repertoire and involve activating KIRs | Q39624540 | ||
| Dermal necrosis and chromosome Iq abnormality in a man with a familial myeloproliferative disorder | Q40228535 | ||
| The human syndrome of dendritic cell, monocyte, B and NK lymphoid deficiency | Q41821656 | ||
| Phenotypic and functional separation of memory and effector human CD8+ T cells | Q42951823 | ||
| Dendritic cell homeostasis is maintained by nonhematopoietic and T-cell-produced Flt3-ligand in steady state and during immune responses. | Q43608868 | ||
| Highly variable clinical manifestations in a large family with a novel GATA2 mutation. | Q43989975 | ||
| Differential cytokine/chemokines and KL-6 profiles in patients with different forms of tuberculosis | Q44147801 | ||
| Age-related trends in pediatric B-cell subsets | Q44305309 | ||
| Flt3-ligand and granulocyte colony-stimulating factor mobilize distinct human dendritic cell subsets in vivo | Q45193405 | ||
| CD56brightCD16+ NK cells: a functional intermediate stage of NK cell differentiation | Q45270327 | ||
| FLT-3 ligand provides hematopoietic protection from total body irradiation in rabbits. | Q47781791 | ||
| GATA-2 anomaly and clinical phenotype of a sporadic case of lymphedema, dendritic cell, monocyte, B- and NK-cell (DCML) deficiency, and myelodysplasia | Q50027819 | ||
| A new CD21low B cell population in the peripheral blood of patients with SLE. | Q51997566 | ||
| Transcription factor GATA-2 is required for proliferation/survival of early hematopoietic cells and mast cell formation, but not for erythroid and myeloid terminal differentiation. | Q52194459 | ||
| Familial Acute Myeloid Leukaemia with Acquired Pelger-Huet Anomaly and Aneuploidy of C Group | Q55178638 | ||
| Mutations in GATA2 cause primary lymphedema associated with a predisposition to acute myeloid leukemia (Emberger syndrome) | Q55671562 | ||
| Emberger syndrome-Primary lymphedema with myelodysplasia: Report of seven new cases | Q57150841 | ||
| Serum Flt3 Ligand Variation as a Predictive Indicator of Hematopoietic Stem Cell Mobilization | Q63384312 | ||
| A family inheriting different subtypes of acute myelogenous leukemia | Q71244330 | ||
| Plasma/serum levels of flt3 ligand are low in normal individuals and highly elevated in patients with Fanconi anemia and acquired aplastic anemia | Q71570774 | ||
| FLT3 ligand preserves the ability of human CD34+ progenitors to sustain long-term hematopoiesis in immune-deficient mice after ex vivo retroviral-mediated transduction | Q72996031 | ||
| Five new pedigrees with inherited RUNX1 mutations causing familial platelet disorder with propensity to myeloid malignancy | Q81820288 | ||
| Marked genetic heterogeneity in familial myelodysplasia/acute myeloid leukaemia | Q83990685 | ||
| Poor prognosis in familial acute myeloid leukaemia with combined biallelic CEBPA mutations and downstream events affecting the ATM, FLT3 and CDX2 genes | Q84195606 | ||
| P433 | issue | 6 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 863-874 | |
| P577 | publication date | 2013-12-17 | |
| P1433 | published in | Blood | Q885070 |
| P1476 | title | The evolution of cellular deficiency in GATA2 mutation | |
| P478 | volume | 123 |
| Q28070339 | '"Why me, why now?" Using clinical immunology and epidemiology to explain who gets nontuberculous mycobacterial infection |
| Q97067620 | A Novel Pathogenic Variant in CARMIL2 (RLTPR) Causing CARMIL2 Deficiency and EBV-Associated Smooth Muscle Tumors |
| Q95318859 | A Panoply of Rheumatological Manifestations in Patients with GATA2 Deficiency |
| Q57510506 | A new genetic tool to improve immune-compromised mouse models: Derivation and CRISPR/Cas9-mediated targeting of NRG embryonic stem cell lines |
| Q90374381 | A novel disease-causing synonymous exonic mutation in GATA2 affecting RNA splicing |
| Q92153255 | Aberrant X chromosome skewing and acquired clonal hematopoiesis in adult-onset common variable immunodeficiency |
| Q40106850 | Acquired Senescent T-Cell Phenotype Correlates with Clinical Severity in GATA Binding Protein 2-Deficient Patients |
| Q40656859 | Acute lymphoblastic leukemia in a patient with MonoMAC syndrome/GATA2 haploinsufficiency |
| Q38956465 | Adaptive NK cells can persist in patients with GATA2 mutation depleted of stem and progenitor cells |
| Q48504653 | Allogeneic Hematopoietic Stem-Cell Transplantation for GATA2 Deficiency Using a Busulfan-Based Regimen. |
| Q39092515 | Allogeneic hematopoietic stem cell transplantation for MDS and CMML: recommendations from an international expert panel |
| Q40165095 | Altered chemotactic response to CXCL12 in patients carrying GATA2 mutations |
| Q33417357 | Autoimmune and other cytopenias in primary immunodeficiencies: pathomechanisms, novel differential diagnoses, and treatment |
| Q41990601 | Autoimmunity/inflammation in a monogenic primary immunodeficiency cohort |
| Q55514852 | Bacille Calmette–Guerin Complications in Newly Described Primary Immunodeficiency Diseases: 2010–2017. |
| Q26739239 | Bone Marrow Immunity and Myelodysplasia |
| Q88400655 | Can somatic GATA2 mutation mimic germ line GATA2 mutation? |
| Q47136225 | Case Report of an Adolescent Male With Unexplained Pancytopenia: GATA2-Associated Bone Marrow Failure and Genetic Testing |
| Q35161496 | Circulating precursors of human CD1c+ and CD141+ dendritic cells |
| Q36276945 | Cis-regulatory mechanisms governing stem and progenitor cell transitions |
| Q42633067 | Collaborating constitutive and somatic genetic events in myeloid malignancies: ASXL1 mutations in patients with germline GATA2 mutations |
| Q38984250 | Dendritic cell analysis in primary immunodeficiency |
| Q52723665 | Diagnosis of GATA2 haplo-insufficiency in a young woman prompted by pancytopenia with deficiencies of B-cell and dendritic cell development. |
| Q52597254 | Differential effects on gene transcription and hematopoietic differentiation correlate with GATA2 mutant disease phenotypes. |
| Q35122462 | Diffuse parenchymal lung disease as first clinical manifestation of GATA-2 deficiency in childhood. |
| Q27003187 | Discovery of single-gene inborn errors of immunity by next generation sequencing |
| Q61627910 | Disruption of an antimycobacterial circuit between dendritic and helper T cells in human SPPL2a deficiency |
| Q90627999 | Emerging insights into human health and NK cell biology from the study of NK cell deficiencies |
| Q38759271 | Exome sequencing identifies highly recurrent somatic GATA2 and CEBPA mutations in acute erythroid leukemia |
| Q91790141 | Flow Cytometry in the Diagnosis and Follow Up of Human Primary Immunodeficiencies |
| Q42353379 | GATA Factor-Dependent Positive-Feedback Circuit in Acute Myeloid Leukemia Cells |
| Q33439175 | GATA factor mutations in hematologic disease |
| Q47548493 | GATA2 Deficiency and Epstein-Barr Virus Disease |
| Q59789119 | GATA2 deficiency and human hematopoietic development modeled using induced pluripotent stem cells |
| Q40163308 | GATA2 deficiency and related myeloid neoplasms |
| Q34802461 | GATA2 deficiency-associated bone marrow disorder differs from idiopathic aplastic anemia. |
| Q35127953 | GATA2 deficiency. |
| Q64108064 | GATA2 hypomorphism induces chronic myelomonocytic leukemia in mice |
| Q64939397 | GATA2 mutation in long stand Mycobacterium kansasii infection, myelodysplasia and MonoMAC syndrome: a case-report. |
| Q40646344 | GATA2 regulates dendritic cell differentiation |
| Q35750225 | GATA2 rs2335052 Polymorphism Predicts the Survival of Patients with Colorectal Cancer |
| Q40331582 | Gain-of-function SAMD9L mutations cause a syndrome of cytopenia, immunodeficiency, MDS, and neurological symptoms |
| Q28067993 | Genetic Causes of Human NK Cell Deficiency and Their Effect on NK Cell Subsets |
| Q33420216 | Genetic predisposition syndromes: when should they be considered in the work-up of MDS? |
| Q33428604 | Genetic predisposition to myelodysplastic syndrome and acute myeloid leukemia in children and young adults |
| Q34798007 | Genomic analysis of bone marrow failure and myelodysplastic syndromes reveals phenotypic and diagnostic complexity |
| Q59355974 | Germline GATA2 Mutation and Bone Marrow Failure |
| Q35535835 | Haematopoietic and immune defects associated with GATA2 mutation |
| Q28263427 | Hematopoietic Signaling Mechanism Revealed from a Stem/Progenitor Cell Cistrome |
| Q55313085 | Herpetic ocular manifestations in a patient with GATA2 deficiency. |
| Q99632860 | Human NK cell deficiency as a result of biallelic mutations in MCM10 |
| Q98719931 | Human NK cells prime inflammatory DC precursors to induce Tc17 differentiation |
| Q89563496 | Human genetics of life-threatening influenza pneumonitis |
| Q57292176 | Human leukemia mutations corrupt but do not abrogate GATA-2 function |
| Q52723704 | Ikaros family zinc finger 1 regulates dendritic cell development and function in humans. |
| Q49359673 | In vivo T-depleted reduced intensity transplantation for GATA2-related immune dysfunction. |
| Q34481015 | Infections caused by non-tuberculous mycobacteria in recipients of hematopoietic stem cell transplantation |
| Q35510477 | Inherited and acquired immunodeficiencies underlying tuberculosis in childhood |
| Q41670964 | Integrating Enhancer Mechanisms to Establish a Hierarchical Blood Development Program |
| Q90740614 | Lessons learned from the study of human inborn errors of innate immunity |
| Q59359537 | Lethal Influenza in Two Related Adults with Inherited GATA2 Deficiency |
| Q41032440 | Loss of B cells and their precursors is the most constant feature of GATA-2 deficiency in childhood myelodysplastic syndrome. |
| Q40873857 | Loss of c-Kit and bone marrow failure upon conditional removal of the GATA-2 C-terminal zinc finger domain in adult mice |
| Q48268381 | Mechanisms of erythrocyte development and regeneration: implications for regenerative medicine and beyond. |
| Q26862947 | Mendelian susceptibility to mycobacterial disease: genetic, immunological, and clinical features of inborn errors of IFN-γ immunity |
| Q40101917 | Modulation of CD4+ T Helper Cell Memory Responses in the Human Skin |
| Q37559777 | Mutational profiling of a MonoMAC syndrome family with GATA2 deficiency |
| Q35871700 | Myeloid Growth Factors Promote Resistance to Mycobacterial Infection by Curtailing Granuloma Necrosis through Macrophage Replenishment |
| Q47923445 | NY-ESO-1 Vaccination in Combination with Decitabine Induces Antigen-Specific T-Lymphocyte Responses in Patients with Myelodysplastic Syndrome |
| Q34619834 | Nonmyeloablative allogeneic hematopoietic stem cell transplantation for GATA2 deficiency |
| Q26830870 | Primary immunodeficiency update: Part II. Syndromes associated with mucocutaneous candidiasis and noninfectious cutaneous manifestations |
| Q51022410 | Severe disseminated primary herpes simplex infection as skin manifestation of GATA2 deficiency. |
| Q36777826 | Single-gene association between GATA-2 and autoimmune hepatitis: A novel genetic insight highlighting immunologic pathways to disease |
| Q35469250 | Spectrum of myeloid neoplasms and immune deficiency associated with germline GATA2 mutations. |
| Q38896796 | Successful umbilical cord blood hematopoietic stem cell transplantation in pediatric patients with MDS/AML associated with underlying GATA2 mutations: two case reports and review of literature |
| Q38558334 | The GATA factor revolution in hematology |
| Q38763233 | Transcriptional and post-transcriptional regulation of NK cell development and function |
| Q35881417 | Young woman with mild bone marrow dysplasia, GATA2 and ASXL1 mutation treated with allogeneic hematopoietic stem cell transplantation |
Search more.